Skip to content
Unrated Drug recall · FDA · Published September 9, 2019

West-Ward Oxcarbazepine Oral Suspension Recall: Impurities May Cause Harm

West-Ward recalls 250mL Oxcarbazepine Oral Suspension due to failed impurities/degradation specifications. Rx-only product with specific lots and expiry dates. Consumers should contact pharmacy for guidance.

🇺🇸 FDA recall #D-1863-2019DrugWest-Ward ›
Take action

Contact the company

Recalling firmWest-Ward Columbus Inc1809 Wilson Rd · Columbus, OH 43228-9579
✎ GovInfoNow plain-language explainer

West-Ward is recalling a prescription oxcarbazepine oral suspension product because it failed impurities and degradation specifications. This could pose a risk to patients taking the medication. Read more at govinfonow.com/recall/38018-west-ward-oxcarbazepine-oral-suspension-recall-impurities-may-cause-harm.

Source Summary by GovInfoNow · govinfonow.com/recall/38018-west-ward-oxcarbazepine-oral-suspension-recall-impurities-may-cause-harm · Updated October 5, 2026 · FDA enforcement record: FDA #D-1863-2019

Cite this page

“West-Ward Oxcarbazepine Oral Suspension Recall: Impurities May Cause Harm.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38018-west-ward-oxcarbazepine-oral-suspension-recall-impurities-may-cause-harm. Based on FDA recall #D-1863-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1863-2019%22&limit=1).

The FDA announced on Sept. 9, 2019, that West-Ward Columbus Inc voluntarily recalled Oxcarbazepine Oral Suspension due to failed impurity specifications. The recall affects 32,347 bottles distributed nationwide and in Puerto Rico.

How to tell if you have it

  • Brand: West-Ward
  • Product: Oxcarbazepine Oral Suspension, USP, 300 mg/5 mL, 250 mL per bottle
  • NDC: 0054-0199-59
  • Lot codes: AA3957A (exp May 2020), AA3958A (exp May 2020), AA5164A (exp Sep 2020)
  • Quantity: 32,347 bottles
  • Distribution: Nationwide USA and Puerto Rico

The hazard

The recall was issued because the Oxcarbazepine Oral Suspension failed impurity specifications. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show West-Ward Columbus Inc has 8 other recalls on record since May 19, 2016. Other recent recalls of similar products include West-Ward Methadone Tablets Recall (Dec. 19, 2024), West-Ward Methotrexate Tablets Recall (Sept. 22, 2023), and West-Ward Recalls Leucovorin Calcium Tablets Due to Labeling Error (July 22, 2020). Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (Dec. 15, 2025), Macleods Olanzapine Tablets 5mg Recall (Aug. 27, 2026), and Sagent Busulfan Injection Recall (May 4, 2026).

How to tell if you have this one

Check the product label for the lot numbers AA3957A, AA3958A, or AA5164A and expiry dates of May 2020 or September 2020. The product is a 250mL bottle of oxcarbazepine oral suspension, prescription-only.

  • Brand
    West-Ward
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Pharmacy

    Talk to your pharmacy about the recalled product and get guidance on next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide USA and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 2.8 years after the firm started it.

1. Firm started the recall: Sep 9, 201912. FDA classified it Class II: Sep 16, 201923. Published in FDA’s Enforcement Report: Sep 25, 201934. FDA terminated the recall: Jun 15, 2022420192022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1863-2019 (September 9, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1863-2019 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA